Articles Related to Ovarian

The clinical course of our patient highlights an atypical presentation of thromboembolic disease related to pregnancy, a thrombophlebitis of the right ovarian vein with endocaval floating thrombus. The diagnosis remains difficult since it is a rare entity with an atypical presentation but with serious medical consequences.

View complete article: PDF  |  Full-text

Weight loss is an efficient therapy for obese polycystic ovary syndrome (PCOS) patients. Here we evaluate the effect of dietary weight reduction on clinical performance in obese PCOS patients. Medical records of fifty obese PCOS patients (age 27 ± 5 years) who had calorie-controlled dietary intervention were reviewed. The patients had a 1200-kcal/day diet until ovulation or for up to three months. Changes in body weight, body mass index (BMI), blood pressure, menstruation, acne, and hirsutusm, serum levels of endocrine hormones and adipocytokines, glucolipid metabolism index and insulin resistance were assessed. Menstrual cycle, ovulation andrelapse in the following six months were also reviewed. All patients had menstrual disorder, 43 had acne, and 26 were hirsute. After weight loss, the BMI decreased from 27.89 ± 3.06 to 25.70 ± 2.42 kg/m2 (p < 0.001). Acne and hirsutusm was improved in 39 and 14 patients, respectively. Regular menstruation was restored in 26 patients and lasted for 3.12 months on average. Endocrine hormones levels, adipocytokines levels, glucolipid metabolism and insulin resistance were shifted toward balance. Weight relapse was seen in 11 patients. No side effects occurred. Dietary intervention in obese PCOS patients can improve relevant clinical problems but weight relapse is an issue

View complete article: PDF  |  Full-text

The use of gonadotropic stimulation in assisted reproductive technology programs increases the risk of developing the ovarian hyperstimulation syndrome (OHSS), which is considered as a loss of control over the ongoing ovarian stimulation. The severe forms of OHSS lead to the severe complications that threaten the patient’s life.

View complete article: PDF  |  Full-text

Recurrence of a mucinous ovarian neoplasm after resection is unusual but this does happen. If possible, a repeat surgical removal of recurrent disease is the treatment of choice. The results of a repeat intervention are poor. A review of our results of treatment of recurrent mucinous ovarian neoplasms was performed.

View complete article: PDF  |  Full-text

This study tested for the effects of generic liposome-encapsulated doxorubicin hydrochloride (generic doxorubicin) compared to reference-pegylated liposomal doxorubicin hydrochloride (reference doxorubicin) as a treatment for patients afflicted with epithelial ovarian carcinoma whose disease has progressed after platinum-based chemotherapy. Chart-reviews of actual patients enrolled in a community-based NIH trial suggest that both generic and reference liposomal doxorubicin hydrochloride (HCl) are equally effective as treatment for ovarian cancer carcinoma.

View complete article: PDF  |  Full-text

Varicose veins next to the testicles and the ovaries are associated with oxidative stress, which can change the phenotype of germinating glands, provoking abnormalities in the hypothalamic-pituitary-gonadal axis. This creates an interference that can express itself in the form of gene mutations in patients with cancer and venous thrombosis. In this study, we made it our goal to evaluate the prevalence of ovarian varicose veins and varicocele in patients with cancer and venous thrombosis and to further investigate this association. In order to achieve this objective, 54 patients with cancer and 98 patients in the control group diagnosed with venous thrombosis were included in this study. All of these patients were examined through ultrasound with vascular Doppler as a means to investigate varicocele in men and ovarian varicose veins in women. Out of a total of 14,800 patients, 152 with cancer and venous thrombosis were selected (1.02%). The group with cancer presented a significantly (p = 0.0029) higher proportion of varicose veins (96.3%) next to the germinating glands than the group with venous thrombosis (84.7%).

View complete article: PDF  |  Full-text

Current cancer treatments by immune checkpoint blockades are limited due to severe adverse events caused by alteration of the immune system required for homeostasis of normal tissues. Common cancer chemotherapy alters the quality of patients’ lives. Platinum-based treatment can lead to severe neurotoxicity with chronic debilitation. Additionally, survival of patients with epithelial ovarian cancers (EOCs) has remained poor despite extensive cytoreductive surgery, high dose chemotherapy, checkpoint blockades and immunotherapies effective in some other types of cancer. The pathobiology of EOC cancer stem cells (CSCs) is not well understood. Observations demonstrate that EOCs exhibit in vivo two distinct CSC types - perivascular diploid CSCs dividing asymmetrically with the help of the host suicidal CD8+ T cells, and haploid CSCs at the cancer abdominal surface originating from meiosis I cytokinesis of bulk surface cancer cells. The perivascular CSCs contribute to the cancer cell bulk and, via left ovary venous blood, can cause EOC liver metastases. Haploid CSCs released from the bulk cancer surface cause the common pelvic and abdominal EOC spread. Former elimination of the host antibodies blocking T cell effectors by intermittent doses of cyclophosphamide exhibiting significant immunomodulatory anticancer effects, facilitation of the immune system reactivity against alloantigens of cancer cells by blood transfusions, and augmentation of anticancer immunity by bacterial toxins, resulted during the subsequent treatment-free period into rejection of inoperable EOCs without any adverse events during the treatnment. To help prevent cancer relapses, patients treated for advanced primary epithelial cancers should be considered as candidates for continuously stimulating immune anticancer activity by treatments such as daily metformin and weekly lentinan consumptions.

View complete article: PDF  |  Full-text

The quadrivalent virus-like particle vaccine against human papillomavirus (QHPV) is a population vaccine targeting peri-pubertal girls and boys. Focus on evaluation of adolescent ovarian safety arises from cases in primary care and published case series describing the development of menstrual dysfunction and idiopathic premature ovarian insufficiency (POI) following QHPV vaccination. A structured review of QHPV vaccine safety studies was performed to answer the question ‘has the ongoing ovarian safety of this vaccine in adolescents been assessed?’ The design, size, and process of pre-licensing safety trials in relation to their capacity to assess ovarian function were reviewed.

View complete article: PDF  |  Full-text

Many scientists and biotechnology companies had given up on the idea of cancer immunotherapy in 1990s. Almost a decade after first detection of T cell suppression effect of CTLA4 the identity of its antibody was established. While they are found effective in many cancers including melanoma, lung cancer etc. immune checkpoint inhibitors have lent an important measure to manage recurrent and refractory ovarian cancer. This subject needs constant updating specially for students of ovarian cancer who are looking at this avenue of cure with much hope.

View complete article: PDF  |  Full-text

Several studies have suggested that Insertion/Deletion polymorphism of ApoB gene is associated with obesity, dyslipidemia, diabetes and coronary heart disease (CHD).

View complete article: PDF  |  Full-text

In assisted reproduction of cattle the design and preparation of in vitro culture media has been instrumental in supporting the development of bovine oocytes and embryos. In vitro production (IVP) involves three main sequential steps: oocyte aspiration and in vitro maturation (IVM); in vitro fertilization (IVF); and in vitro culture (IVC) of early pre-implantation embryos.

View complete article: PDF  |  Full-text

A 13 year old, premenarchal, previously healthy girl presented to the emergency department of our hospital with complaints of vomiting, constipation and abdominal pain for past one day. The patient also complained of slowly increasing abdominal distension and mild abdominal discomfort since past four months.

View complete article: PDF  |  Full-text

A study of the history of the dermoid cyst of the ovary suggests that the old masters were only conversant with large tumors. The relatively smaller dermoid cyst with its typical greasy matter and hairs only came into recognition during the second half of the 19th century. Therefore, the purpose of this paper is to document how the medical masters of yester years became acquainted with this distinct disease.

View complete article: PDF  |  Full-text

Assisted reproductive technologies, such as artificial insemination and embryo transfer, have produced significant outcomes in cattle. These technologies are useful not only for improving fertility but also for increasing the rate of genetic change in beef and dairy livestock. Today, embryo transfer in cattle is both practical and commercially viable. However, bovine embryo transplantation still remains suboptimal under on-farm conditions, one of the main reasons for which may be inefficient nutritional management.

View complete article: PDF  |  Full-text

The high mortality associated with ovarian cancer is generally related to the development of drug-resistant disease. HMGA2 protein, a member of the high-mobility group AT-hook (HMGA) family of non-histone chromatin binding factors, is overexpressed in high-grade serous ovarian and tubal carcinomas, though little is known about its contribution to disease progression and drug resistance. We sought to assess whether compositional changes in HMGA2 production were associated with ovarian cancer progression.

View complete article: PDF  |  Full-text